A Closer Look at FIGS, Inc.’s Downgrade by Analysts

Photo of author
Written By Marcus Reynolds

The financial landscape of FIGS, Inc. (NYSE: FIGS), a renowned player in the medical apparel industry, has recently been the subject of scrutiny.

Analysts have adjusted their forecasts downward, signaling potential headwinds that might dampen shareholders’ enthusiasm.

This reevaluation has precipitated an 8.1% uptick in share price to US$5.61 over the last week, an interesting development against the backdrop of revised expectations.

Detailed Analysis of Financial Forecasts

In a surprising turn, analysts have collectively revised their revenue and earnings projections for FIGS, Inc., indicating a cautious or pessimistic outlook for the year ahead.

For 2024, the consensus among FIGS’ eleven analysts now pegs revenues at approximately US$539 million, aligning closely with the figures reported over the last twelve months.

Credit: DepositPhotos

A stark adjustment is observed in the statutory earnings per share (EPS), which is expected to plummet by 55% to US$0.06 in the same timeframe. Prior to this revision, analysts were slightly more optimistic, forecasting revenues of US$547 million and an EPS of US$0.075 for 2024.

This downward adjustment in forecasts underscores a notable decline in analyst sentiment, particularly evidenced by the significant reduction in EPS expectations.

This sentiment shift could potentially have far-reaching implications for investor confidence and market performance of FIGS, Inc.

Read More: Israeli Business Software Provider Magic Software Enterprises Stands at Critical Juncture

Industry Context and Historical Performance

To fully appreciate the gravity of these revised forecasts, it’s crucial to contextualize FIGS, Inc.’s projections within the broader industry landscape and its historical growth trajectory.

The anticipated 1.3% annualized revenue decline through the end of 2024 starkly contrasts with the company’s impressive historical growth rate of 21% over the last three years.

This projected downturn not only signifies a departure from FIGS’ growth narrative but also positions the company unfavorably against an industry expected to see an average annual revenue growth of 7.0%.

Industry and FIGS’ Strategic Outlook

The adjustment in FIGS’ financial outlook raises critical questions about its strategic positioning and operational efficiency. While the company’s revenues are expected to contract, this trend does not align with the overall industry’s growth prospects.

The broader industry’s anticipated expansion suggests a mismatch between FIGS’ strategy and market demands or perhaps reflects the company’s specific challenges in adapting to evolving consumer preferences and competitive pressures.

Also Read: Clinical Study Updates Prompt a Surge in Stoke Therapeutics’ Stock

Implications and Strategic Considerations for FIGS, Inc.

The revised analyst forecasts for FIGS, Inc. highlight a series of strategic and operational considerations for the company.

The clear decline in earnings, coupled with a conservative revenue outlook, points towards the need for FIGS to reassess its market strategy, product offerings, and cost management practices.

Credit: DepositPhotos

The company may need to innovate more aggressively, streamline its operations further, or explore new market segments to rekindle growth and realign with industry trends.

Investors, in turn, are faced with a complex decision-making landscape. The downgraded outlook might prompt some to reconsider their investment stance on FIGS, weighing the potential for short-term volatility against the company’s long-term growth prospects.

The key will be to monitor how FIGS responds to these challenges, particularly in terms of product innovation, market expansion, and cost control measures.

Read Next: Brazilian Banking Entity Inter & Co, Inc. Surged By 230% in Last Year – Will the Surge Continue?


You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.